Daniel G Tenen
Daniel G Tenen
Cancer Science Institute, National University of Singapore
Verified email at
Cited by
Cited by
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
S Kobayashi, TJ Boggon, T Dayaram, PA Jšnne, O Kocher, M Meyerson, ...
New England Journal of Medicine 352 (8), 786-792, 2005
Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak
M Dai, D Liu, M Liu, F Zhou, G Li, Z Chen, Z Zhang, H You, M Wu, ...
Cancer discovery 10 (6), 783-791, 2020
Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice
DE Zhang, P Zhang, N Wang, CJ Hetherington, GJ Darlington, DG Tenen
Proceedings of the National Academy of Sciences 94 (2), 569-574, 1997
Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
T Pabst, BU Mueller, P Zhang, HS Radomska, S Narravula, S Schnittger, ...
Nature genetics 27 (3), 263-270, 2001
Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species
R Zilionis, C Engblom, C Pfirschke, V Savova, D Zemmour, HD Saatcioglu, ...
Immunity 50 (5), 1317-1334. e10, 2019
Transcription factors, normal myeloid development, and leukemia
DG Tenen, R Hromas, JD Licht, DE Zhang
Blood, The Journal of the American Society of Hematology 90 (2), 489-519, 1997
Disruption of differentiation in human cancer: AML shows the way
DG Tenen
Nature reviews cancer 3 (2), 89-101, 2003
Transcription factors in myeloid development: balancing differentiation with transformation
F Rosenbauer, DG Tenen
Nature Reviews Immunology 7 (2), 105-117, 2007
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα
P Zhang, J Iwasaki-Arai, H Iwasaki, ML Fenyus, T Dayaram, BM Owens, ...
Immunity 21 (6), 853-863, 2004
CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors
HS Radomska, CS Huettner, PU Zhang, TAO Cheng, DT Scadden, ...
Molecular and cellular biology 18 (7), 4301-4314, 1998
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1
F Rosenbauer, K Wagner, JL Kutok, H Iwasaki, MM Le Beau, Y Okuno, ...
Nature genetics 36 (6), 624-630, 2004
AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t (8; 21) myeloid leukemia
T Pabst, BU Mueller, N Harakawa, C Schoch, T Haferlach, G Behre, ...
Nature medicine 7 (4), 444-451, 2001
Negative cross-talk between hematopoietic regulators: GATA proteins repress PU. 1
P Zhang, G Behre, J Pan, A Iwama, N Wara-Aswapati, HS Radomska, ...
Proceedings of the National Academy of Sciences 96 (15), 8705-8710, 1999
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
DB Costa, B Halmos, A Kumar, ST Schumer, MS Huberman, TJ Boggon, ...
PLoS medicine 4 (10), e315, 2007
DNMT1-interacting RNAs block gene-specific DNA methylation
A Di Ruscio, AK Ebralidze, T Benoukraf, G Amabile, LA Goff, J Terragni, ...
Nature 503 (7476), 371-376, 2013
The macrophage transcription factor PU. 1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor
DE Zhang, CJ Hetherington, HM Chen, DG Tenen
Molecular and cellular biology 14 (1), 373-381, 1994
Distinctive and indispensable roles of PU. 1 in maintenance of hematopoietic stem cells and their differentiation
H Iwasaki, C Somoza, H Shigematsu, EA Duprez, J Iwasaki-Arai, ...
Blood 106 (5), 1590-1600, 2005
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
H Ji, D Li, L Chen, T Shimamura, S Kobayashi, K McNamara, U Mahmood, ...
Cancer cell 9 (6), 485-495, 2006
Reversibility of acute B-cell leukaemia induced by BCR–ABL1
CS Huettner, P Zhang, RA Van Etten, DG Tenen
Nature genetics 24 (1), 57-60, 2000
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
L Chen, Y Li, CH Lin, THM Chan, RKK Chow, Y Song, M Liu, YF Yuan, ...
Nature medicine 19 (2), 209-216, 2013
The system can't perform the operation now. Try again later.
Articles 1–20